# Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma

> **NCT01406574** · PHASE1,PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 23 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** OPB-31121
- **DRUG:** OPB-31121 phase2

## Key facts

- **NCT ID:** NCT01406574
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406574, "Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01406574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*